BIRC5 and breast carcinoma: Pathway enrichment analysis of paclitaxel-residual cells suggests that short-term paclitaxel treatment sensitizes TNBC breast cancer cells to apoptosis mainly via upregulation of TNFα pathway coupled to downregulation of survivin transcription and G2/M cell cycle arrest mediated partially by the transcription factor E2F (Figure 4).